Clinical Trial Update: Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on efficacy and safety of albumin-bound paclitaxel as first-line chemotherapy for ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Paclitaxel (albumin-bound) for injection (paclitaxel albumin-bound formulation)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN